# Cryo Cell International Inc: Form 10-Q/A for the period ended Aug 31, 2011

- Company: [Cryo Cell International Inc](/companies/ccel.md) (CIK 862692)
- Form: 10-Q/A
- Filed: 2011-11-07
- Accepted by EDGAR: Nov 7, 2011, 21:47 ET
- Period: 2011-08-31
- Accession: 0001193125-11-299944
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/862692/000119312511299944/d212691d10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/862692/000119312511299944/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-08-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-06-01 to 2011-08-31 | $4.4m | us-gaap:Revenues |
| Revenue | 9 months, 2010-12-01 to 2011-08-31 | $13.5m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2011-06-01 to 2011-08-31 | $1.2m | us-gaap:CostOfServices |
| Cost of revenue | 9 months, 2010-12-01 to 2011-08-31 | $3.5m | us-gaap:CostOfServices |
| Research and development | 3 months, 2011-06-01 to 2011-08-31 | $52.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2010-12-01 to 2011-08-31 | $168.5k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2011-06-01 to 2011-08-31 | $5.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2010-12-01 to 2011-08-31 | $10.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2011-06-01 to 2011-08-31 | −$1.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2010-12-01 to 2011-08-31 | −$586.9k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2011-06-01 to 2011-08-31 | $409.5k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2010-12-01 to 2011-08-31 | $1.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2011-06-01 to 2011-08-31 | $39.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2010-12-01 to 2011-08-31 | $108.8k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-06-01 to 2011-08-31 | −$2.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2010-12-01 to 2011-08-31 | −$2.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-06-01 to 2011-08-31 | −$0.20 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2010-12-01 to 2011-08-31 | −$0.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-06-01 to 2011-08-31 | −$0.20 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2010-12-01 to 2011-08-31 | −$0.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2011-06-01 to 2011-08-31 | 11,757,803 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2010-12-01 to 2011-08-31 | 11,754,324 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2010-12-01 to 2011-08-31 | $459.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2010-12-01 to 2011-08-31 | $560.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2011-08-31 | $5.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-08-31 | $13.2m | us-gaap:AssetsCurrent |
| Total assets | at 2011-08-31 | $18.6m | us-gaap:Assets |
| Current liabilities | at 2011-08-31 | $9.7m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2011-08-31 | $3.8m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2011-08-31 | −$2.4m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/862692/000119312511299944/d212691d10qa.htm

Filed Nov 7, 2011.
Source: SEC EDGAR, the filing index for accession 0001193125-11-299944. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.